Functional improvement of hemostatic dressing by addition of recombinant batroxobin
- PMID: 27769944
- DOI: 10.1016/j.actbio.2016.10.024
Functional improvement of hemostatic dressing by addition of recombinant batroxobin
Abstract
Although a number of natural materials have been used as hemostatic agents, many substances do not act quickly enough. Here, we created a novel dressings using collagen and chitosan with recombinant batroxobin (r-Bat) to promote faster and more effective hemostasis. We hypothesized that r-Bat would promote synergetic blood coagulation because it contains a blood coagulation active site different than those of collagen and chitosan. Our results suggest that each substances can maintain hemostatic properties while in the mixed dressings and that our novel hemostatic dressings promotes potent control of bleeding, as demonstrated by a whole blood assay and rat hemorrhage model. In a rat femoral artery model, the scaffold with a high r-Bat concentration more rapidly controlled excessive bleeding. This novel dressings has enormous possible for rapidly controlling bleeding and it improves upon the effect of collagen and chitosan used alone. Our novel r-Bat dressings is a possible candidate for improving preoperative care and displays promising properties as an absorbable agent in hemostasis.
Statement of significance: Despite the excellent hemostatic properties of collagen and chitosan pads, they reported to brittle behavior and lack sufficient hemostatic effect within relevant time. Therefore, we created a novel pad using collagen and chitosan with recombinant batroxobin (r-Bat). r-Bat acts as a thrombin-like enzyme in the coagulation cascade. Specifically, r-Bat, in contrast to thrombin, only splits fibrinopeptide A off and does not influence other hemostatic factors or cells, which makes it clinically useful as a stable hemostatic agent. Also the materials in the pad have synergetic effect because they have different hemostatic mechanisms in the coagulation cascade. This report propose the novel hemostatic pad isreasonable that a great potential for excessive bleeding injury and improve effects of natural substance hemostatic pad.
Keywords: Coagulation; Hemostasis; Hemostatic dressings; Natural substance; Recombinant batroxobin.
Copyright © 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Recombinant batroxobin-coated nonwoven chitosan as hemostatic dressing for initial hemorrhage control.Int J Biol Macromol. 2018 Jul 1;113:757-763. doi: 10.1016/j.ijbiomac.2018.03.017. Epub 2018 Mar 4. Int J Biol Macromol. 2018. PMID: 29514041
-
The effective control of a bleeding injury using a medical adhesive containing batroxobin.Biomed Mater. 2014 Apr;9(2):025002. doi: 10.1088/1748-6041/9/2/025002. Epub 2014 Jan 31. Biomed Mater. 2014. PMID: 24487019
-
Slounase, a Batroxobin Containing Activated Factor X Effectively Enhances Hemostatic Clot Formation and Reducing Bleeding in Hypocoagulant Conditions in Mice.Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211018510. doi: 10.1177/10760296211018510. Clin Appl Thromb Hemost. 2021. PMID: 34047195 Free PMC article.
-
Research progress and application of chitosan dressings in hemostasis: A review.Int J Biol Macromol. 2024 Dec;282(Pt 1):136421. doi: 10.1016/j.ijbiomac.2024.136421. Epub 2024 Oct 9. Int J Biol Macromol. 2024. PMID: 39389479 Review.
-
A review on recent advances in chitosan based composite for hemostatic dressings.Int J Biol Macromol. 2019 Mar 1;124:138-147. doi: 10.1016/j.ijbiomac.2018.11.045. Epub 2018 Nov 14. Int J Biol Macromol. 2019. PMID: 30447365 Review.
Cited by
-
Composite Hemostatic Nonwoven Textiles Based on Hyaluronic Acid, Cellulose, and Etamsylate.Materials (Basel). 2020 Apr 1;13(7):1627. doi: 10.3390/ma13071627. Materials (Basel). 2020. PMID: 32244805 Free PMC article.
-
A Prospective, Multicenter, Randomized, Noninferiority Trial of Stopad® Versus Tachosil® for Hemostasis After Liver Resection.Cancers (Basel). 2025 Feb 23;17(5):757. doi: 10.3390/cancers17050757. Cancers (Basel). 2025. PMID: 40075603 Free PMC article.
-
Perioperative blood loss of sequential administration of hemocoagulase Agkistrodon and Tranexamic acid for primary total knee arthroplasty: a randomized controlled trial.J Orthop Surg Res. 2025 May 13;20(1):457. doi: 10.1186/s13018-025-05867-0. J Orthop Surg Res. 2025. PMID: 40355919 Free PMC article. Clinical Trial.
-
Oxidized Bacterial Cellulose Membranes Immobilized with Papain for Dressing Applications: Physicochemical and In Vitro Biological Properties.Pharmaceutics. 2024 Aug 18;16(8):1085. doi: 10.3390/pharmaceutics16081085. Pharmaceutics. 2024. PMID: 39204430 Free PMC article.
-
Use of Batroxobin in Central and Peripheral Ischemic Vascular Diseases: A Systematic Review.Front Neurol. 2021 Dec 2;12:716778. doi: 10.3389/fneur.2021.716778. eCollection 2021. Front Neurol. 2021. PMID: 34925203 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials